Lemonaid Health raises $33 million Series B

San Francisco-based healthcare provider Lemonaid Health has raised a $33 million Series B round of funding, bringing its total funding to $55 million. The round was led by Olive Tree Ventures with participation from Artis Ventures, Correlation Ventures, Hikma Ventures, Sierra Ventures and others.

Founded in 2014, Lemonaid offers patients direct access to the care they need, from consultation through treatment nationally across the US. Its proprietary technology platform integrates clinical algorithms and decision support tools with clinician care to provide better quality care and improved outcomes.

“The U.S. healthcare system has struggled to deliver the services patients need in a way that is convenient and effective. The challenges of providing routine care has been exacerbated recently as the majority of health resources have been focused on responding to the coronavirus pandemic. We founded Lemonaid Health with a vision to increase access to affordable, high-quality healthcare. As more consumers have turned to telehealth in the last six months, we’ve seen significant growth in demand for our online services. With the additional financing, we will be able to help even more patients get the care they deserve and expand our services in partnership with other healthcare providers.” – Paul Johnson, co-founder and CEO of Lemonaid Health.

“The current pandemic and surge in COVID-19 cases pushed health systems to the brink. Services like Lemonaid Health have helped alleviate the burden on health systems, giving patients a safe and speedy alternative to in-person care. By connecting directly with patients in need and seamlessly providing consultative services and treatments, Paul and his team are taking a cutting-edge approach to addressing the backlog of need in today’s healthcare environment. We are excited to partner with Lemonaid Health to realize the full potential of technology in re-envisioning the future of healthcare.” – Alejandro Weinstein, general partner at Olive Tree Ventures.